Automating Critical Care EEG: Enhancing Accuracy,Efficiency,and Patient Outcomes in Critical Care

Abstract

The rapid expansion of continuous EEG (cEEG) monitoring in critically ill patients has created a growing gap between data acquisition and the clinical capacity to interpret these data in a timely manner. This mismatch has emerged alongside major advances in EEG automation, which promise to support more efficient and clinically integrated interpretation. At the same time, evidence guiding the optimal, safe, and ethically responsible use of these tools remains limited. In this review, we trace the historical development of EEG analysis methods from early automation to contemporary AI-based approaches and examine their application in neurocritical care. We discuss the potential benefits and limitations of quantitative EEG and AI for EEG processing, as well as the role of AI in supporting clinical decision-making in these populations when integrated with electronic medical record systems. By focusing on practical implementation and real-world constraints, we aim to show how automated and AI-assisted tools can augment, rather than replace, clinical expertise and help improve the timeliness and quality of patient-centered care.

Introduction

Timing is a critical determinant in neurocritical care and is particularly consequential in the management of patients monitored with continuous electroencephalography (cEEG). Clinical decisions in this setting depend on the timely recognition of seizures, evolving cerebral dysfunction, medication lapses, and secondary brain injury, where delays or premature interventions can meaningfully affect outcomes. The fundamental tension between intervening too early—risking unnecessary treatment or resource utilization—and intervening too late—allowing potentially preventable neurologic injury—underscores the need for accurate, time-sensitive interpretation of both physiologic and clinical data.

The widespread adoption of cEEG has transformed care in the intensive care unit by enabling prolonged, real-time monitoring of brain activity. However, this expansion has also generated an unprecedented volume of data, placing substantial demands on limited neurophysiology expertise and creating challenges for timely interpretation. At the same time, critical clinical context—medication exposure, dosing changes, clinical trajectories, and outcomes—is often embedded in fragmented electronic medical record (EMR) systems, limiting the ability to synthesize EEG findings with the broader clinical picture in real time.

Automation and quantitative analysis have emerged as essential strategies to address these challenges across both cEEG and EMR domains. Importantly, the value of automation lies not in replacing clinical judgment, but in supporting it. This review examines the evolving role of automation in cEEG and its integration with EMR. We explore how quantitative EEG (qEEG), automated analytics, and EMR harmonization can help navigate the balance between early and delayed intervention, using real-world implementation examples to highlight both successes and limitations. The overarching goal is to provide a pragmatic framework for integrating automated cEEG and EMR tools into routine neurocritical care workflows to support timely, accurate, and patient-centered decision-making.

From Quantitative EEG to Artificial Intelligence: A Historical Perspective on Automated EEG Analysis Tools

Since Hans Berger's first human EEG recording in 1924, EEG has undergone a remarkable transformation. ¹ The transition from paper-based systems to digital EEG in the 1970s enabled storage, re-review, and quantitative analysis, catalyzing computational neurophysiology. ² Digitalization enabled spectral power methods and coherence analysis, leading to the development of qEEG, which after initial use in research, entered clinical practice to support seizure detection, encephalopathy assessment, and neurocritical care monitoring.

Over time, advances in invasive recording techniques, including electrocorticography (ECoG) and depth electrodes, offer higher spatial resolution and a better signal-to-noise ratio, enabling the investigation of mesoscopic neural networks and the detection of deep seizure foci. ³ The development of stereo-EEG (SEEG) has transformed presurgical epilepsy evaluation by providing millimeter-scale sampling across cortical and subcortical regions, thereby improving seizure onset zone localization and mapping of eloquent cortex. ³ More recently, single-unit and multi-unit recordings in select neurosurgical settings have enabled direct measurement of neuronal activity in humans, highlighting the expanding scale of modern brain monitoring, from global rhythms to single-neuron activity. ⁴ These high-resolution invasive techniques are increasingly being used in neurocritical care, allowing the detection of seizures missed on scalp EEG monitoring and the detection of spreading depolarizations. ⁵

In parallel, computational neuroscience has transformed EEG analysis through statistical modeling and machine learning. ⁶ Early automated EEG systems relied on rule-based algorithms or template matching to detect epileptiform discharges or seizures. The subsequent deep learning revolution introduced convolutional and recurrent neural networks, as well as self-attention methods, which can learn hierarchical features directly from raw EEG data, achieving increasingly high accuracy in seizure detection, sleep staging, epileptiform classification, and outcome prediction.^7–11 These methods also underpin brain–computer interfaces (BCIs), which decode neural activity to enable communication, motor control, or sensory feedback.^12,13 Although still largely experimental, BCIs signal a conceptual transformation: EEG is no longer solely a diagnostic tool but an information-rich substrate capable of supporting real-time neural decoding. Recent studies in neurocritical care have shown that up to one in four patients may display signs of covert consciousness through the use of noninvasive monitoring with EEG and fMRI.^14,15

Despite these advances, clinical adoption in neurocritical care remains limited. Continuous EEG (cEEG), which has become an indispensable neuromonitoring technique in the intensive care unit, remains resource intensive. While qEEG and automated seizure detection tools support nonexperts’ interpretation, real-world performance remains variable.^16,17 Many artificial-intelligence (AI)-based EEG algorithms perform well in controlled research datasets yet generalize poorly across institutions, hardware platforms, or patient populations. Variability in electrode montages, impedance, artifact profiles, annotation quality, and labeling standards remains a barrier. Clinical skepticism persists given the high-stakes nature of EEG interpretation and the limited number of FDA-cleared tools. Likewise, access to high-density EEG, SEEG, and advanced computational infrastructure remains concentrated in academic epilepsy centers, highlighting the disparities in epilepsy diagnosis and treatment.

Nonetheless, AI-enabled EEG analysis holds potential for democratizing access to high-quality EEG interpretation, particularly in hospitals without full-time electroencephalographers. ¹⁸ Emerging point-of-care EEG systems that are portable and can be placed rapidly by nonexperts facilitate the acquisition of EEG in emergency departments, rural facilities, and low-resource settings. ¹⁹ Combined with robust automated algorithms for seizure detection or triage and cloud-based platforms, these systems may reduce diagnostic delays and standardized EEG interpretation across healthcare systems.

From Hans Berger's first recordings to AI-powered systems, EEG evolution reflects a century-long convergence of neuroscience, engineering, and clinical innovation. Clinicians must match these powerful technologies with rigorous validation, equitable dissemination, and interdisciplinary collaboration that is patient centered. ²⁰

To Quantify or not to Quantify—The Role of Quantitative EEG in Clinical Practice

Advantages and Promise of Quantitative EEG in the ICU

The expansion of cEEG monitoring has created a data overflow, qEEG enables rapid, purpose-driven review of large data files by applying computational and statistical techniques to digitize EEG signals through commercially available displays designed for tasks such as seizure detection, and ischemia monitoring. Time-based compression of EEG with visual display of trends allows for a “bird's eye” view of large EEG files. qEEG has demonstrated value in reducing the cEEG review time that would otherwise demand a lengthy and labor-intensive assessment. In a multicenter study using review of five qEEG panels for seizure detection in the ICU, the review time for a 6-h epoch was 19 min for raw EEG compared to 6 min for qEEG alone, and 14.5 min when raw EEG was used with qEEG. ²¹

Despite the advantage of reducing reading time, the primary driver for qEEG adoption is improved efficiency of seizure detection. ²² Most experts commonly used rhythmicity spectrogram, automated seizure detection, Fast Fourier Transformation (FFT) spectrogram, and amplitude-integrated EEG (aEEG). ²³ Compressed spectral array (CSA) use alone allowed detection of a median of 94.2% of seizures in adults (FPR of 13.7 per seizure identified). ²⁴ In children, seizure detection rate were 83.3% using color density spectral array (CDSA) and 81.5% using aEEG (false positives every 17–20 h). ²⁵ In a study, where multiple panels were used, qEEG review alone detected seizures with a sensitivity of 51–67% (FPR 1/h) and when raw EEG was available, the sensitivity was 63–68% (FPR 0.5/h). ²¹ A qEEG terminology has been proposed to describe qEEG changes in a manner that reflects the underlying EEG findings, such as solid flames and irregular flames for seizures, broad band monotonous for periodic discharges, narrow band monotonous for rhythmic delta and stripes for burst suppression. ²⁶ Solid flames have shown to have better correlation with raw EEG seizures than irregular flames. False positive flame patterns can be due to EEG slowing and artifacts.

qEEG democratizes expertise; with simplified panels and targeted training, non-neurophysiologists, such as ICU nurses and fellows, can screen seizures with sensitivities approaching the level of expert neurophysiologists. ²⁷ This capability facilitates a scalable, 24/7 seizure triage model that empowers the bedside team. In a study comparing nurses (after undergoing brief training) with neurophysiologists, nurses had a higher sensitivity for seizure detection at 73.8% compared to 66.3% for neurophysiologists, but the false positive rate was twice that of neurophysiologists (1/3.2 vs 1/6.4 h). ¹⁶ Certain panels may be more user-experience dependent than the others such as envelope trend compared to CSA. ²⁸

Beyond seizure detection, qEEG can be used to monitor crucial physiologic biomarkers in the critically ill. The correlation of progressive EEG change (from loss of faster frequencies to EEG slowing leading to suppression) with decreasing cerebral blood flow is the basis for this use.^29,30 In subarachnoid hemorrhage (SAH), qEEG offers an early warning system for delayed cerebral ischemia (DCI). Metrics such as the alpha/delta ratio (ADR) and relative alpha variability (RAV) can detect ischemic changes days before clinical deterioration occurs.^31,32 A two-grade drop of RAV has been shown to have a perfect sensitivity for detecting DCI and this change preceded the diagnosis of vasospasm by a mean of 2.9 days. ³³ A >10% drop in ADRs from baseline has a 100% sensitivity and 76% specificity for vasospasm detection. ³⁴ Small case series have shown qEEG changes to precede clinical changes by several hours in those with elevated ICP,^33,34 with spectral power serving as a continuous sentinel that can signal potential decompensation hours before irreversible damage.^35,36 Additionally, this has been applied in large vessel occlusion causing ischemic stroke.

Finally, qEEG aids objective prognostication. In postcardiac arrest coma, analysis of burst-suppression trajectories offers high specificity for poor outcomes. ³⁷ As we move toward the integration of AI, machine learning models utilizing spectral band power and entropy are beginning to outperform human visual analysis in predicting neurologic recovery. ³⁸ The transition from qualitative reading to quantitative analysis thus generates a paradigm shift in neurocritical care, from a reactive stance to an anticipatory one.

Pitfalls and limitations of qEEG

Despite the promises described above, qEEG is not without pitfalls. The raw EEG features of seizures determine what panel would reliably pick up seizures as individual panels represent different aspects of raw EEG. Asymmetry spectrogram has a high sensitivity (94%) for focal seizures but may fail to detect generalized seizures and may display focal to generalized seizures as focal alone. ³⁹ FFT spectrogram has a high sensitivity for focal to generalized seizures (84%) and CDSA for generalized seizures (79%). Rhythmicity spectrogram has poor sensitivity for focal seizures (29%). ³⁹ There are seizure characteristics that make them hard to detect by qEEG as well. Low voltage (<75 µV), short duration (<1 min), focal, and seizures of low frequency and those in a background of periodic discharges are less likely to be detected by qEEG.^21,25 Higher seizure amplitude than the background and their propagation beyond the onset make detection by qEEG more likely.^21,25

User experience and training also add variability to the accuracy of qEEG. The sensitivity of qEEG for its various discussed indications is probably reasonable; however, the false positives make clinical implementation challenging across its use indications. This is aligned with other AI-based seizure detection algorithms, where false positivity needs to be addressed. Additional implementation challenges for EEG-based AI algorithms are often based in the lack of a true comparative gold standard, unknown significance of missing brief subclinical seizures, and variable research methodology between studies. Additionally, there is variable interpretation of ictal-interictal continuum (IIC) EEG patterns by experts, a possible difference in the performance of algorithm in controlled versus clinical settings. Likewise, the expert (reference standard) performance in a research setting (possible perceived as being “observed”) maybe different than in a clinical setting. With respect to sensitivity, it is possible that some AI-based algorithms perform at the level of an average EEGer which our research methodology could be failing to capture.

Until the above aspects are addressed, in its current state, qEEG should be used in conjunction with raw EEG, it can guide raw EEG review but is not ready to replace a concomitant raw EEG review (Table 1).

Table 1.

Advantages and limitations of qEEG.

Advantages	Limitations
Greater review efficiency: Trend displays allow rapid screening of long EEG segments and reduce overall reading time.	Variable sensitivity: Performance differs across panels and seizure types; low-voltage, brief, or focal seizures may be missed.
Improved seizure detection: qEEG supports earlier identification of ictal patterns and complements raw EEG interpretation.	High false-positive rates: False alarms remain a major challenge and complicate clinical implementation.
Broader usability: With targeted training, non-neurophysiologists can screen for seizures and support continuous monitoring.	Dependence on user expertise: Accuracy varies with experience, and some displays require more training than others.
Detection of physiological deterioration: qEEG trends (ADR, RAV, spectral power) can signal ischemia or rising ICP before clinical decline.	Inability to replace raw EEG: Morphological detail and spatial information are reduced; qEEG must be interpreted alongside raw data.
Supports prognostication: Quantitative metrics and machine-learning models contribute to prediction after cardiac arrest.	Methodologic challenges: Lack of a gold standard, variability in algorithm performance, and inconsistent expert benchmarks limit reliability.

Advancing Critical Care EEG: Integrating Machine Learning, Language Processing, and EEG Innovations

With the increasing use of cEEG in critical care, there has been growing recognition of periodic and rhythmic patterns (RPPs), including periodic discharges, rhythmic delta activity, and the IIC. ⁴⁰ Cohort studies have demonstrated that these patterns are frequently associated with electrographic seizures and worse clinical outcomes, although their independent contribution to brain injury remains uncertain.^41–43

There is ongoing debate regarding whether RPPs contribute directly to secondary brain injury or instead represent an epiphenomenon reflecting the severity of the underlying cerebral insult. ⁴³ Multimodal physiologic studies suggest that higher-frequency periodic discharges may be associated with increased cerebral metabolic stress, supporting a potential causal role in neuronal injury. ⁴⁴ However, observational data remain conflicting, and causality has not been definitively established.^42,45 Given the limited evidence base, practice variation exist in the use of anti-seizure medications (ASMs) for RPPs, particularly for patterns that do not meet electrographic seizure criteria.^46,47 This reflects uncertainty regarding treatment thresholds, duration, and ASMs choice, underscoring the need to identify which patients benefit from treatment and the optimal therapeutic approach.^46,47

Although randomized controlled trials (RCTs) are considered the gold standard for evaluating treatment effectiveness, they are particularly challenging in this population. ⁴⁸ Barriers include the complex and rapidly evolving physiology of critically ill patients, the dynamic nature of RPPs, the heterogeneity of acute brain injury subtypes, and unclear treatment targets (clinical outcomes vs. EEG resolution). Additional challenges include unknown ASM treatment efficacy, multiple drug classes and dosing strategies, the confounding impact of anesthetics and sedatives, and significant recruitment and consent barriers in the ICU setting.

When RCTs are infeasible, modern causal inference methods applied to real-world data provide a powerful alternative for estimating treatment effects. ⁴⁸ To support these analyses, it is essential to generate large, multicenter, richly phenotyped datasets linking high-resolution neurophysiologic data with detailed EMR information. Recent advances in AI have made scalable phenotyping of EEG and clinical data possible.^49–51

Automated EEG classifiers capable of detecting seizures and classifying rhythmic and periodic patterns at scale, ⁴⁹ and algorithms to automatically quantify the frequency and spatial extent of RPPs ⁵⁰ overcome the limitations of manual EEG annotation. In parallel, natural language processing models can extract key clinical variables from the EMR at scale. Additionally, these data can be used to inform the design of future randomized trials, including studies of EEG-guided antiseizure treatment. ⁵¹

In summary, AI-enabled phenotyping of large, linked EEG–EMR datasets enables the generation of rigorous real-world evidence and provides a scalable pathway to advance evidence-based care in critical care EEG monitoring.

Enhancing Communication, Clinical Practice, and Research through EMR-based EEG Reporting

Over the past several years, rapid advances in AI and precision medicine have transformed what is technically possible in neurological care. Yet, despite these innovations, everyday clinical epilepsy and critical care practice remain constrained by fragmented data pipelines, inconsistent documentation, and a lack of scalable analytical frameworks. ⁵² In response to this, the Emory Epilepsy Group, working closely with the Emory working in collaboration with the Goizueta Institute Data Platform, has initiated a comprehensive effort to harmonize EEG, medication, and clinical documentation data into a single ecosystem. The aim is to create the foundation necessary for routine analytics, predictive tools, and clinically meaningful AI deployment (Figure 1).

Figure 1.

Brain Health Data Platform. Copyright by Emory University. Reproduced with Permission.

To achieve this, the team has re-engineered the institutional EEG repository. Historically, EEG data were stored as raw, siloed files, approximately 800 terabytes spanning more than 10,000 scalp EEG studies without a standardized downstream structure. The repository is now evolving toward a dual model that maintains on-demand access to raw data while prioritizing derivative, noise-filtered, analysis-ready data products. This work spans the entire clinical spectrum, including EMR EEG records, EMU and ICU monitoring, and surgical datasets. In parallel, the clinical medication infrastructure was redesigned through creation of structured order sets and the introduction of automated dashboards that monitor refill run-rates, with the goal of preventing lapses in ASM adherence.

Clinical documentation has undergone similar transformation. New hybrid EMR note templates combine discrete data elements with flexible free-text, incorporating physician feedback, professional guidelines, and national standards. These templates are built not only for clinician usability, but also to ensure that data can be algorithmically extracted in the future. A HIPAA-compliant large language model was piloted to automatically extract structured outcomes and seizure classifications directly from unstructured notes, laying the groundwork for a scalable, automated documentation pipeline.

These initiatives are already yielding measurable results. Emory has played a leading role in the national MORGOTH consortium, contributing to the development of an ICU EEG AI model trained in 6095 labeled studies and achieving expert-level diagnostic accuracy. ⁵³ Locally, the seizure prediction model originally trained on inpatient critical-care EEG is now being adapted for EMU and outpatient settings. Medication standardization has dramatically narrowed order variability from more than 5000 permutations to a manageable standardized library making it possible to accurately predict when patients will run out of medication and to intervene proactively. Making the data accessible has led to several projects that include a national study of EEG, treatment, subarachnoid hemorrhage, and EEG features of abnormal cognition. The institution now operates active dashboards tracking ICU EEG and surgical patients. Meanwhile, standardized physician documentation approaches have produced 80–90% agreement between physicians and automated large language model (LLM) extraction and generated the structure needed for future projects that can help us collect outcome data automatically. Another area explored is that patient-reported outcomes have expanded substantially, with more than 700 structured surveys collected, revealing gaps in existing MyChart follow-up pathways.

Taken together, this effort demonstrates that comprehensive data harmonization, ranging from EEG repositories to clinical documentation to medication analytics can serve as a practical foundation for AI in epilepsy and ICU care. Importantly, the approach prioritizes clinician adoption, usability, and interoperability, ensuring that innovation is grounded in real clinical workflows rather than constructed around research silos. Looking ahead, the program is preparing to connect the LLM pipeline to health record systems, expand predictive dashboards across the enterprise, and sustain a multi-institutional EEG data lake across partners.

Conclusions

Automated software, computational and statistical analysis of digitized EEG, and structured EMR data have the potential to significantly enhance epilepsy and neurocritical care field by improving data accuracy, compliance, and efficiency. The areas outlined in this summary provide a historical perspective on how we arrived at the current landscape, as well as the advantages and limitations of incorporating technology into clinical workflows.

Ongoing research and real-world clinical applications of these technologies represent critical areas for continued growth. Equally important is the ethical and appropriate implementation of these tools at the institutional level, ensuring compliance with local regulations and alignment with cultural and practice norms. In summary, automation in EEG analysis and EMR (templates, order set, repository, etc.) represents a meaningful advancement in critical care, providing structured support for EEG interpretation and clinical decision-making when deliberately designed to enhance the quality of patient care.